| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigations |
1 Department of Nuclear Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas
2 Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
3 Department of Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, Texas
4 Department of Imaging Physics, University of Texas M.D. Anderson Cancer Center, Houston, Texas
As SPECT/CT technology evolves, its applications and indications need to be evaluated clinically for more efficient and cost-effective use. This retrospective study evaluated the clinical value of simultaneously acquired 99mTc-sestamibi SPECT/CT versus conventional SPECT in diagnosing and locating parathyroid adenomas or hyperplasia in patients with primary hyperparathyroidism. Methods: Immediately and 60 minutes after intravenous administration of 740–925 MBq of 99mTc-sestamibi, static planar images of the neck and chest were obtained. SPECT/CT images were acquired 30 minutes after injection. Two experienced masked readers independently evaluated whether conventional SPECT images provided information beyond what was available from the planar images either by changing the diagnosis or by better locating the glands and whether the SPECT/CT images provided information beyond what was available from the planar plus conventional SPECT images. Forty-eight consecutive patients with a clinical diagnosis of primary hyperparathyroidism were included in the study. The 32 whose scans showed positive results underwent surgical resection and were examined histopathologically. Results: Planar and SPECT imaging, with or without CT fusion, identified 89% of the surgically confirmed diseased parathyroid glands. Use of SPECT/CT changed the diagnosis in only 1 patient (2%) from positive to negative and better located the glands in only 4 patients (8%). SPECT/CT was particularly helpful in locating the 2 ectopic parathyroid adenomas diagnosed in this cohort. Tracer retention in diseased glands did not correlate with histologic characteristics. Also, biochemical markers did not correlate with the scan findings. Conclusion: SPECT/CT has no significant clinical value additional to that of conventional SPECT for parathyroid imaging except in locating ectopic parathyroid glands. Eliminating the CT acquisition will spare patients the additional time, radiation exposure, and expense.
Key Words: parathyroid adenoma • SPECT/CT • hyperparathyroidism • parathyroid scintigraphy • radionuclide
Related articles in JNM:
This article has been cited by other articles:
|
|
 |
|
  M. C. Roarke, B. D. Nguyen, and B. A. Pockaj Applications of SPECT/CT in Nuclear Radiology Am. J. Roentgenol., September 1, 2008; 191(3): W135 - W150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Buck, S. Nekolla, S. Ziegler, A. Beer, B. J. Krause, K. Herrmann, K. Scheidhauer, H.-J. Wester, E. J. Rummeny, M. Schwaiger, et al. SPECT/CT J. Nucl. Med., August 1, 2008; 49(8): 1305 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Nichols, M. B. Tomas, G. G. Tronco, J. N. Rini, B. D. Kunjummen, K. S. Heller, L. A. Sznyter, and C. J. Palestro Preoperative Parathyroid Scintigraphic Lesion Localization: Accuracy of Various Types of Readings Radiology, July 1, 2008; 248(1): 221 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bybel, R. C. Brunken, F. P. DiFilippo, D. R. Neumann, G. Wu, and M. D. Cerqueira SPECT/CT Imaging: Clinical Utility of an Emerging Technology RadioGraphics, July 1, 2008; 28(4): 1097 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Toniato, D. Casara, and M. Pelizzo The Negative Sestamibi Scan: Is a Minimally Invasive Parathyroidectomy Still Possible? Ann. Surg. Oncol., January 1, 2008; 15(1): 378 - 379. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Taieb, R. Hassad, F. Sebag, C. Colavolpe, E. Guedj, E. Hindie, J.-F. Henry, and O. Mundler Tomoscintigraphy Improves the Determination of the Embryologic Origin of Parathyroid Adenomas, Especially in Apparently Inferior Glands: Imaging Features and Surgical Implications J. Nucl. Med. Technol., September 1, 2007; 35(3): 135 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Lavely, S. Goetze, K. P. Friedman, J. P. Leal, Z. Zhang, E. Garret-Mayer, A. P. Dackiw, R. P. Tufano, M. A. Zeiger, and H. A. Ziessman Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid Scintigraphy J. Nucl. Med., July 1, 2007; 48(7): 1084 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hara, T. Takayama, M. Onoguchi, N. Obane, T. Miyati, T. Yoshioka, K. Sakaguchi, and M. Honda Subtraction SPECT for Parathyroid Scintigraphy Based on Maximization of Mutual Information J. Nucl. Med. Technol., June 1, 2007; 35(2): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Johnson, M. E. Tublin, and J. B. Ogilvie Parathyroid Imaging: Technique and Role in the Preoperative Evaluation of Primary Hyperparathyroidism Am. J. Roentgenol., June 1, 2007; 188(6): 1706 - 1715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Strobel, C. Burger, B. Seifert, D. B. Husarik, J. D. Soyka, and T. F. Hany Characterization of Focal Bone Lesions in the Axial Skeleton: Performance of Planar Bone Scintigraphy Compared with SPECT and SPECT Fused with CT Am. J. Roentgenol., May 1, 2007; 188(5): W467 - W474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Delbeke, R. E. Coleman, M. J. Guiberteau, M. L. Brown, H. D. Royal, B. A. Siegel, D. W. Townsend, L. L. Berland, J. A. Parker, G. Zubal, et al. Procedure Guideline for SPECT/CT Imaging 1.0 J. Nucl. Med., July 1, 2006; 47(7): 1227 - 1234. [Full Text] [PDF]
|
|
|
|
|
|
A. F. Scarsbrook, R. V. Thakker, J. A. H. Wass, F. V. Gleeson, and R. R. Phillips Multiple Endocrine Neoplasia: Spectrum of Radiologic Appearances and Discussion of a Multitechnique Imaging Approach. RadioGraphics, March 1, 2006; 26(2): 433 - 451. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
